<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04036175</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A02838-45</org_study_id>
    <nct_id>NCT04036175</nct_id>
  </id_info>
  <brief_title>Comparison of Patient Work of Breathing and Tidal Volumes With High Flow Nasal Cannula Oxygen Therapy and NIV (Non-Invasive Ventilation) After Extubation in the ICU.</brief_title>
  <acronym>OVNI</acronym>
  <official_title>Comparison of Patient Work of Breathing and Tidal Volumes With High-flow Nasal Cannula Oxygen Therapy and Non-invasive Ventilation After Extubation in the ICU: a Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed at evaluating patient work of breathing and tidal volumes with three
      methods of oxygenation: standard oxygen, high-flow oxygen therapy and non-invasive
      ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2018</start_date>
  <completion_date type="Anticipated">March 6, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient respiratory effort and tidal volume (Vt)</measure>
    <time_frame>1h20</time_frame>
    <description>Swing of oesophageal pressure and pressure-Time product measured by a nasogastric pressure sensor tidal Volume estimated by electric impedance tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory parameters</measure>
    <time_frame>&quot;Time 0&quot;,&quot;Time 20 min&quot;, &quot;Time 40 min&quot;, &quot;Time 60 min&quot;, &quot;Time 120 min&quot;</time_frame>
    <description>respiratory rate (FR bt/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory parameters</measure>
    <time_frame>&quot;Time 0&quot;,&quot;Time 20 min&quot;, &quot;Time 40 min&quot;, &quot;Time 60 min&quot;, &quot;Time 120 min&quot;</time_frame>
    <description>saturation (SpO2 in %)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory parameters</measure>
    <time_frame>&quot;Time 0&quot;,&quot;Time 20 min&quot;, &quot;Time 40 min&quot;, &quot;Time 60 min&quot;, &quot;Time 120 min&quot;</time_frame>
    <description>transcutaneous CO2 pressure (PCO2 in mm Hg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory parameters</measure>
    <time_frame>&quot;Time 0&quot;,&quot;Time 20 min&quot;, &quot;Time 40 min&quot;, &quot;Time 60 min&quot;, &quot;Time 120 min&quot;</time_frame>
    <description>transpulmonary pressure (cm H2O)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic parameters</measure>
    <time_frame>&quot;Time 0&quot;,&quot;Time 20 min&quot;, &quot;Time 40 min&quot;, &quot;Time 60 min&quot;, &quot;Time 120 min&quot;</time_frame>
    <description>Systolic arterial pressure (PAS in mmHg), Diastolic arterial pressure (PAD in mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort evaluation</measure>
    <time_frame>&quot;Time 0&quot;,&quot;Time 20 min&quot;, &quot;Time 40 min&quot;, &quot;Time 60 min&quot;, &quot;Time 120 min&quot;</time_frame>
    <description>comfort evaluation with an visual evaluation scale graduate 0 cm (No discomfort) to 10 cm (maximal discomfort)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>ICU</condition>
  <condition>Extubation</condition>
  <condition>Non-invasive Ventilation</condition>
  <condition>High-Flow Nasal Oxygen Therapy</condition>
  <condition>Respiratory Effort</condition>
  <condition>Work of Breathing</condition>
  <condition>Tidal Volume</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard oxygen - High-Flow Nasal Oxygen - Non-invasive ventilation - Standard Oxygen (20 minutes for each condition)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard oxygen - Non-invasive ventilation - High-Flow Nasal Oxygen - Standard Oxygen (20 minutes for each condition)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-Flow Nasal Oxygen / Non-invasive ventilation / Standard oxygen</intervention_name>
    <description>Device High Flow Nasal Oxygen: gas flow of 50L:Min and FiO2 adjusted to obtain SpO2&gt;= 92% Device NIV: Pressure-support level to achieve an expired tidal volume between 6 and 8 ml/kg and PEEP level of 5 cmH2O and FiO2 adjusted for SpO2&gt;= 92%</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age: 18 years

          -  planned extubation decided by the physician in charge of the patient after success of
             weaning trial

          -  patients at high risk of reintubation according to the following criteria: patient
             older than 65 years, or those having any underlying chronic cardiac or lung disease

          -  Hypoxemia defined by PaO2/FiO2 &lt; 300 mmHg under mechanical ventilation before
             extubation

        Exclusion Criteria:

          -  Duration of mechanical ventilation prior to extubation &lt; 24h

          -  Contraindication to NIV

          -  Contraindication to nasogastric tube

          -  Do-not-reintubated order at time of extubation

          -  People under legal protection

          -  Opposition to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud W. THILLE, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medecine intensive reanimation CHU Poitiers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud W. THILLE, PUPH</last_name>
    <phone>+33 5 49 44 38 54</phone>
    <email>arnaud.thille@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>CÃ©line DELETAGE</last_name>
    <email>celine.deletage@chu-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud W THILLE, Pr</last_name>
      <phone>05 49 44 38 54</phone>
      <email>arnaud.thille@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive reanimation</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud THILLE</last_name>
      <phone>+33 5 49 44 38 54</phone>
    </contact>
    <contact_backup>
      <last_name>Jean-Pierre FRAT</last_name>
      <phone>+33 5 49 44 38 54</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2019</study_first_posted>
  <last_update_submitted>July 29, 2019</last_update_submitted>
  <last_update_submitted_qc>July 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

